State Specialty Directory
Rheumatology in NY
Federal CMS data for 209 rheumatology providers across NY. Includes Medicare utilization, Open Payments industry funding, and PECOS enrollment status.
209
Providers
Median industry payments
$4,844
209
Rheumatology Providers
in NY
$4,844
Median Industry Payments
per provider (2018–2024)
1,652
Median Medicare Services
fee-for-service claims
How to read this directory: Providers are listed by Medicare service volume, which reflects only
Medicare fee-for-service patients (typically 65+). This does not represent total practice volume.
Industry payments span multiple years and payment types; disclosure alone establishes neither wrongdoing nor legality.
Rheumatology includes multiple subspecialties with different practice patterns.
Learn more →
Showing top 50 of 209 providers, ranked by Medicare service volume. Search by city to narrow results.
Rheumatology Providers — NY
NPPES · Open Payments · Medicare| Provider | City | Medicare Volume | Beneficiaries* | Top Procedure | Industry Payments | Payment Type | Coverage |
|---|---|---|---|---|---|---|---|
| GRUBER, BARRY M.D. | Babylon | 300,657 | — | Romosozumab injection (Evenity) for osteoporosis | $853,539 (2018-2024) | — | Very High |
| BRODSKY, JORDAN M.D. | Hewlett | 231,991 | — | Certolizumab injection (Cimzia) | $48,254 (2018-2024) | — | Very High |
| KHAIRALLAH, RAMZI MD | Syracuse | 175,937 | — | Tocilizumab injection (Actemra) | $2,045 (2018-2024) | — | Very High |
| FURIE, RICHARD M.D. | New Hyde Park | 150,965 | — | Injection, belatacept, 1 mg | $672,007 (2018-2024) | — | Very High |
| XU, HONG M.D. | Smithtown | 141,496 | — | Certolizumab injection (Cimzia) | $36,915 (2018-2024) | — | Very High |
| KRASNOKUTSKY, SVETLANA M.D. | Purchase | 136,838 | — | Certolizumab injection (Cimzia) | $4,022 (2018-2024) | — | Very High |
| VUONG, VICTORIA D.O. | Babylon | 133,987 | — | Certolizumab injection (Cimzia) | $30,966 (2018-2024) | — | Very High |
| MARINESCU, LUIZIANA M.D. | Smithtown | 128,993 | — | Certolizumab injection (Cimzia) | $23,288 (2018-2024) | — | Very High |
| SCHULMAN, PAUL M.D. | Smithtown | 122,473 | — | Certolizumab injection (Cimzia) | $68,199 (2018-2024) | — | Very High |
| DASCALU, COSMIN MD | Babylon | 117,567 | — | Certolizumab injection (Cimzia) | $25,785 (2018-2024) | — | Very High |
| BLUMSTEIN, HOWARD M.D. | Smithtown | 116,940 | — | Certolizumab injection (Cimzia) | $47,626 (2018-2024) | — | Very High |
| MTANOS, GEORGE MD | Syracuse | 114,361 | — | Tocilizumab injection (Actemra) | $1,657 (2018-2024) | — | Very High |
| ABDULKY, MARY MD | Syracuse | 111,018 | — | Tocilizumab injection (Actemra) | $1,446 (2018-2024) | — | Very High |
| MONGROO, RANA | Hewlett | 108,431 | — | Certolizumab injection (Cimzia) | $20,919 (2019-2024) | — | Very High |
| KLEIN, ASAF M.D. | Hewlett | 96,777 | — | Certolizumab injection (Cimzia) | $25,788 (2018-2024) | — | Very High |
| PATEL, UMESH M.D. | Fishkill | 80,074 | — | Certolizumab injection (Cimzia) | $14,206 (2018-2024) | — | Very High |
| GOLDSTEIN, MARK MD | Staten Island | 76,983 | — | Certolizumab injection (Cimzia) | $35,790 (2018-2024) | — | Very High |
| WEITZ, ZE'EV M.D. | Duanesburg | 72,318 | — | Tocilizumab injection (Actemra) | $13,802 (2018-2024) | — | Very High |
| RUMORE, PETER M.D. | Smithtown | 71,945 | — | Certolizumab injection (Cimzia) | $14,971 (2018-2023) | — | Very High |
| LANS, DAVID DO FACP | New Rochelle | 64,368 | — | Certolizumab injection (Cimzia) | $14,544 (2018-2024) | — | Very High |
| PRASHAD, ROY D.O. | Riverhead | 53,534 | — | Golimumab infusion (Simponi Aria) | $99,536 (2018-2024) | — | Very High |
| WYSELL, MARYANNE MD | Poughkeepsie | 46,660 | — | Certolizumab injection (Cimzia) | $666 (2018-2024) | — | Very High |
| SCHWARTZFARB, LANNY M.D. | New York | 44,119 | — | Certolizumab injection (Cimzia) | $5,040 (2018-2024) | — | Very High |
| VAN DE STOUWE, MARJORIE MD | Rockville Centre | 42,228 | — | Golimumab infusion (Simponi Aria) | $7,145 (2018-2024) | — | Very High |
| CHATPAR, PREM M.D. | Plainview | 37,796 | — | Golimumab infusion (Simponi Aria) | $9,626 (2018-2024) | — | Very High |
| PASNICIUC, MARIA MD | Syracuse | 37,132 | — | Tocilizumab injection (Actemra) | $1,079 (2019-2024) | — | Very High |
| LIPSTEIN-KRESCH, ESTHER MD | New Hyde Park | 35,163 | — | Denosumab injection (Prolia/Xgeva) | $5,006 (2018-2024) | — | Very High |
| BRYAN, RICHARD MD | Queensbury | 32,298 | — | Golimumab infusion (Simponi Aria) | $247,442 (2018-2024) | — | Very High |
| MUND, DOUGLAS M.D. | New Hyde Park | 30,389 | — | Denosumab injection (Prolia/Xgeva) | $8,373 (2018-2024) | — | Very High |
| TAMBAR, PREM M.D | Niagara Falls | 29,938 | — | Abatacept infusion (Orencia) | $5,573 (2018-2024) | — | Very High |
| BERGER, JACK MD | Purchase | 29,700 | — | Certolizumab injection (Cimzia) | $2,069 (2018-2024) | — | Very High |
| HAQ, MAHJABEEN D.O. | Babylon | 27,876 | — | Denosumab injection (Prolia/Xgeva) | $16,265 (2018-2024) | — | Very High |
| COHEN, HARLEY MD | Nesconset | 24,423 | — | Denosumab injection (Prolia/Xgeva) | $810 (2018-2024) | — | Very High |
| KAPLAN, STUART M.D. | Hewlett | 24,332 | — | Denosumab injection (Prolia/Xgeva) | $28,193 (2018-2024) | — | Very High |
| GODDARD, DAVID MD | Brooklyn | 23,010 | — | Denosumab injection (Prolia/Xgeva) | $2,746 (2021-2024) | — | Very High |
| JOHNSON, SARA M.D. | Smithtown | 22,949 | — | Tocilizumab injection (Actemra) | $13,203 (2018-2023) | — | Very High |
| DISSICK, ADDIE M.D. | Babylon | 22,518 | — | Denosumab injection (Prolia/Xgeva) | $17,320 (2018-2024) | — | Very High |
| MORELL, MARTIN MD | New Hartford | 22,027 | — | Golimumab infusion (Simponi Aria) | $69,906 (2018-2024) | — | Very High |
| GUPTA, SANDEEP M.D. | Bronx | 19,335 | — | Denosumab injection (Prolia/Xgeva) | $21,759 (2018-2024) | — | Very High |
| SILVERBERG, MIRIAM MD | Buffalo | 17,080 | — | Denosumab injection (Prolia/Xgeva) | $1,516 (2018-2024) | — | Very High |
| CHAPMAN, JESSICA MD | Queensbury | 17,047 | — | Abatacept infusion (Orencia) | $1,202 (2018-2024) | — | Very High |
| KLAHR, JONATHAN MD | Cedarhurst | 16,145 | — | Denosumab injection (Prolia/Xgeva) | $9,899 (2018-2024) | — | Very High |
| CHADHA, SUNITA M.D. | Williamsville | 16,136 | — | Golimumab infusion (Simponi Aria) | $311,176 (2018-2024) | — | Very High |
| IENOPOLI, SABATINO D.O. | Forest Hills | 15,003 | — | Denosumab injection (Prolia/Xgeva) | $24,997 (2018-2024) | — | Very High |
| DREINER, UTE M.D. | New Hartford | 13,172 | — | Golimumab infusion (Simponi Aria) | $6,955 (2018-2024) | — | Very High |
| HAMBURGER, MAX M.D. | Melville | 10,398 | — | Denosumab injection (Prolia/Xgeva) | $322,863 (2018-2024) | — | Very High |
| WEINGARTEN, MICHAEL M.D. | West Seneca | 10,074 | — | Infliximab infusion (Remicade) | $3,459 (2018-2024) | — | Very High |
| STEIN, BRUCE MD | Floral Park | 9,741 | — | Abatacept infusion (Orencia) | $39,578 (2018-2024) | — | Very High |
| MOSAK, JOSEPH M.D. | Staten Island | 8,712 | — | Denosumab injection (Prolia/Xgeva) | $258 (2019-2023) | — | Very High |
| WRIGHT, GRACE MD | New York | 8,525 | — | Denosumab injection (Prolia/Xgeva) | $3,167,249 (2018-2024) | — | Very High |
Note: Rheumatology encompasses multiple subspecialties with different practice patterns.
Differences in payment amounts and procedure volumes may reflect subspecialty focus
rather than practice quality. Consider viewing individual profiles for full context.